Peng Hui, Yang Chunzheng, Liang Wei Qi Jing, Huang Niu , Guo Zongru, . STRUCTURE-ACTIVITY RELATIONSHIP OF PHENOTHIAZINES FOR INHIBITION OF PROTEIN KINASE C AND REVERSAL OF MULTIDRUG RESISTANCEJ. Acta Pharmaceutica Sinica, 1999, 34(2): 114-118.
Citation: Peng Hui, Yang Chunzheng, Liang Wei Qi Jing, Huang Niu , Guo Zongru, . STRUCTURE-ACTIVITY RELATIONSHIP OF PHENOTHIAZINES FOR INHIBITION OF PROTEIN KINASE C AND REVERSAL OF MULTIDRUG RESISTANCEJ. Acta Pharmaceutica Sinica, 1999, 34(2): 114-118.

STRUCTURE-ACTIVITY RELATIONSHIP OF PHENOTHIAZINES FOR INHIBITION OF PROTEIN KINASE C AND REVERSAL OF MULTIDRUG RESISTANCE

  • AIM: To study the structure-activity relationship of phenothiazines(PTZs) for inhibition of protein kinase C (PKC) and reversal of multidrug resistance (MDR) in vitro. METHODS and RESULTS: The possible binding model of PTZs to PKC based upon the X-ray structure of PMA(phorbol myristic acetate) in complex with PKC Cys 2 with DOCK program was explored. The results showed that the order of potency of reversal effect of PTZs on MDR is as follows: 2-COC3H7>2-CF3>2-COCH3>H. The type of piperazinyl substitution also significantly affected potency against MDR. The result showed the order: CH3>COOC2H5>C2H4OH. CONCLUSION: Some derivatives of PTZ was tested for inhibition of PKC. The observation indicates that PTZs inhibit PKC in a manner related to specific structural feature. Our molecular-modeling study suggests preliminarily how these PTZs bind to PKC and provide a structural basis for the design of high affinity PKC-modulator. Our structure-activity studies offer a way to understand which molecular structure affects activity, and this information may be used in the rational design of more effective drugs.
  • loading

Catalog

    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return